Cipla
Amit Korgaonkar currently serves as Director at Cipla since October 2022. Previously, Amit held multiple leadership roles at The Janssen Pharmaceutical Companies of Johnson & Johnson from August 2014 to October 2022, including Business Unit Head and National Sales Head. Amit's career also includes significant experience at Roche Diagnostics India, where the role of Area Business Manager was held from May 2012 to August 2014, and several positions at Sanofi, starting as Scientific Sales Executive and advancing to Area Business Manager from June 2006 to April 2012. Early in the career, Amit worked as a Sales Officer at SRL Diagnostics and as a Sales Executive at Zydus Group. Amit holds an EPBM in Business Administration and Management from the Indian Institute of Management, Calcutta (2018-2019), and a B.Sc. in Chemistry from SPK College (1997-2000).
This person is not in any teams
This person is not in any offices
Cipla
17 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.